JP2004520436A5 - - Google Patents

Download PDF

Info

Publication number
JP2004520436A5
JP2004520436A5 JP2002574767A JP2002574767A JP2004520436A5 JP 2004520436 A5 JP2004520436 A5 JP 2004520436A5 JP 2002574767 A JP2002574767 A JP 2002574767A JP 2002574767 A JP2002574767 A JP 2002574767A JP 2004520436 A5 JP2004520436 A5 JP 2004520436A5
Authority
JP
Japan
Prior art keywords
vitamin
rda
composition
copper
zinc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002574767A
Other languages
English (en)
Japanese (ja)
Other versions
JP3672554B2 (ja
JP2004520436A (ja
Filing date
Publication date
Priority claimed from US09/816,284 external-priority patent/US6660297B2/en
Application filed filed Critical
Publication of JP2004520436A publication Critical patent/JP2004520436A/ja
Application granted granted Critical
Publication of JP3672554B2 publication Critical patent/JP3672554B2/ja
Publication of JP2004520436A5 publication Critical patent/JP2004520436A5/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2002574767A 2001-03-23 2002-03-19 黄斑変性を処置するための栄養補助剤 Expired - Lifetime JP3672554B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/816,284 US6660297B2 (en) 2001-03-23 2001-03-23 Nutritional supplement to treat macular degeneration
PCT/US2002/008451 WO2002076242A1 (en) 2001-03-23 2002-03-19 Nutritional supplement to treat macular degeneration

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2003417383A Division JP2004346058A (ja) 2001-03-23 2003-12-15 黄斑変性を処置するための栄養補助剤

Publications (3)

Publication Number Publication Date
JP2004520436A JP2004520436A (ja) 2004-07-08
JP3672554B2 JP3672554B2 (ja) 2005-07-20
JP2004520436A5 true JP2004520436A5 (enExample) 2005-09-29

Family

ID=25220168

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2002574767A Expired - Lifetime JP3672554B2 (ja) 2001-03-23 2002-03-19 黄斑変性を処置するための栄養補助剤
JP2003417383A Pending JP2004346058A (ja) 2001-03-23 2003-12-15 黄斑変性を処置するための栄養補助剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2003417383A Pending JP2004346058A (ja) 2001-03-23 2003-12-15 黄斑変性を処置するための栄養補助剤

Country Status (18)

Country Link
US (3) US6660297B2 (enExample)
EP (3) EP1516542B1 (enExample)
JP (2) JP3672554B2 (enExample)
KR (1) KR100539633B1 (enExample)
CN (1) CN1279844C (enExample)
AR (1) AR034220A1 (enExample)
AT (2) ATE281085T1 (enExample)
BR (2) BRPI0208640B1 (enExample)
CA (1) CA2449892C (enExample)
DE (2) DE60201824T2 (enExample)
DK (1) DK1383399T3 (enExample)
ES (2) ES2231692T3 (enExample)
IL (2) IL158034A0 (enExample)
MX (1) MXPA03008606A (enExample)
PT (1) PT1383399E (enExample)
SG (1) SG126764A1 (enExample)
WO (1) WO2002076242A1 (enExample)
ZA (1) ZA200307241B (enExample)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7164035B2 (en) * 2000-01-07 2007-01-16 Newsome David A Zinc-monocysteine complex and method of using zinc-cysteine complexes
US6660297B2 (en) * 2001-03-23 2003-12-09 Bausch & Lomb Incorporated Nutritional supplement to treat macular degeneration
US9192586B2 (en) 2003-03-10 2015-11-24 Zeavision Llc Zeaxanthin formulations with additional ocular-active nutrients, for protecting eye health and treating eye disorders
DE20300304U1 (de) * 2003-01-09 2003-04-24 Dr. Gerhard Mann Chem.-pharm. Fabrik GmbH, 13581 Berlin Ocuvite Zink
DE20300305U1 (de) 2003-01-09 2003-04-24 Mann Gerhard Chem Pharm Fab Ocuvite Lutein
US20050112210A1 (en) * 2003-09-12 2005-05-26 Terry Grossman Eye nutritional supplement
US7842722B2 (en) * 2003-12-19 2010-11-30 Alcon, Inc. Composition and methods for inhibiting the progression macular degeneration and promoting healthy vision
DE20320101U1 (de) * 2003-12-23 2004-04-29 Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh Mikronährstoffkombinationsprodukt geeignet zur ergänzenden bilanzierten Diät bei altersbedingter Makuladegeneration
WO2005083430A1 (en) * 2004-02-25 2005-09-09 Massachusetts Eye & Ear Infirmary Biomarkers for age-related macular degeneration (amd)
US20050249820A1 (en) * 2004-05-04 2005-11-10 Akorn, Inc. Nutritional supplement for the treatment and prevention of macular degeneration
US7887847B2 (en) * 2004-05-08 2011-02-15 Paul Jr Edward L Nutritional supplement for treatment of ocular diseases
US7351424B2 (en) * 2004-07-22 2008-04-01 Bio Lut S.A. De C.V. Enhanced purity trans-lutein-ester compositions and methods of making same
US20060134226A1 (en) * 2004-11-16 2006-06-22 Todd Leonard Compositions useful to treat ocular neovascular diseases and macular degeneration
AU2006230201A1 (en) * 2005-03-31 2006-10-05 A.P. Pharma, Inc. PEG-polyacetal diblock and triblock copolymers and pharmaceutical compositions
JP2006333802A (ja) * 2005-06-03 2006-12-14 Pola Chem Ind Inc ニキビ用の食品組成物
US20070148106A1 (en) * 2005-06-15 2007-06-28 Karin Wertz Treatment, prevention, and modulation of aging of the skin
CN101262855A (zh) * 2005-09-08 2008-09-10 帝斯曼知识产权资产管理有限公司 治疗或预防年龄相关性黄斑变性的方法
JP5085329B2 (ja) * 2005-09-12 2012-11-28 協和発酵バイオ株式会社 α−リポ酸含有組成物
DE102005043379B4 (de) * 2005-09-16 2008-01-31 Uvex Arbeitsschutz Gmbh Arbeitsschutzbrillen
US20070065487A1 (en) * 2005-09-21 2007-03-22 Bio Lut S.A. De C.V. Trans-lutein xantophyll ester of high purity and high bioavailability in micellar solution and a process for the preparation thereof
US20070082064A1 (en) * 2005-10-12 2007-04-12 Krawitz Paul L Nutritional or dietary supplement for the treatment of macular degeneration
US9770433B2 (en) 2006-01-19 2017-09-26 The Regents Of The University Of Michigan Composition and method for treating tinnitus
US9889156B2 (en) 2006-01-19 2018-02-13 The Regents Of The University Of Michigan Method for treating noise-induced hearing loss (NIHL)
US10238599B2 (en) 2006-01-19 2019-03-26 The Regents Of The University Of Michigan Composition and method for treating congenital cytomegalovirus induced hearing loss
US8338397B2 (en) * 2006-01-19 2012-12-25 The Regents Of The University Of Michigan Composition and method of treating side effects from antibiotic treatment
USRE46372E1 (en) 2006-01-19 2017-04-25 The Regents Of The Univerity Of Michigan Method for treating hearing loss
US9919008B2 (en) 2006-01-19 2018-03-20 The Regents Of The University Of Michigan Method for treating age-related hearing loss (ARHL)
US8927528B2 (en) 2006-01-19 2015-01-06 The Regents Of The University Of Michigan Composition for treating hearing loss
US20090155390A1 (en) * 2006-01-19 2009-06-18 Miller Josef M Composition and method of treating temporary and permanent hearing loss
US7951845B2 (en) * 2006-01-19 2011-05-31 The Regents Of The University Of Michigan Composition and method of treating hearing loss
US7786100B2 (en) * 2006-03-20 2010-08-31 The Regents Of The University Of Michigan Composition and method of treating hearing loss
CA2654303C (en) * 2006-06-08 2016-07-26 The Iams Company Use of at least one polyphenol for promoting eye health
US20110082218A1 (en) * 2006-06-15 2011-04-07 Karin Wertz Treatment and modulation of gene expression and skin aging
US7282225B1 (en) 2006-09-27 2007-10-16 Occular Technologies, Inc. Composition and methods for improving retinal health
US20080095757A1 (en) * 2006-10-23 2008-04-24 Now Health Group, Inc. Vitamin c compositions
US20080181972A1 (en) * 2007-01-29 2008-07-31 Valentina Amico Compositions and Methods for Maintaining, Strengthening, Improving, or Promoting Eye Health
US8491937B2 (en) * 2007-02-15 2013-07-23 Wyeth Llc Stability in vitamin and mineral supplements
USRE47045E1 (en) * 2007-09-12 2018-09-18 The Trustees Of Columbia University In The City Of New York Compositions and methods for treating macular degeneration
JP2010538674A (ja) 2007-09-19 2010-12-16 オフサルモファーマ・アクチェンゲゼルシャフト 栄養補助剤およびそのような補助剤を含む強化食品
US20090118228A1 (en) * 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
US20090226547A1 (en) * 2008-03-05 2009-09-10 Gilbard Jeffrey P Dietary Supplement For Eye Health
US9173862B2 (en) * 2008-04-18 2015-11-03 Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of The University Of Arizona Methods and compositions for treating and identifying compounds to treat age-related macular degeneration
WO2009129859A1 (en) 2008-04-24 2009-10-29 Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh Compositions and methods for maintaining, strengthening, improving, or promoting eye health
CN101595977B (zh) * 2008-06-02 2013-04-03 浙江医药股份有限公司新昌制药厂 有益于眼睛明视持久度的配方食品及其应用
EP2493484A4 (en) * 2009-11-01 2013-03-27 Synthetic Biolog Inc GASTRORENTENTAL ORAL PREPARATIONS WITH HIGH ZINC CONTENT
EP2542096B1 (en) 2010-03-05 2015-07-15 Ophthalmopharma AG Nutraceutical chocolate or compound chocolate product
US9125940B2 (en) * 2011-02-03 2015-09-08 Zhuning Ma Compositions and methods for treating macular edema
US8652518B2 (en) * 2012-04-15 2014-02-18 Jahahreeh Finley Compositions and methods for the prevention and treatment of diseases or conditions associated with oxidative stress, inflammation, and metabolic dysregulation
WO2014052880A1 (en) 2012-09-28 2014-04-03 Disilvestro Robert Nutritional supplements for eye health and related methods
WO2014182635A1 (en) 2013-05-08 2014-11-13 Baldwin Megan E Biomarkers for age-related macular degeneration (amd)
EP3273783B1 (en) 2015-03-26 2025-09-10 Omniactive Health Technologies Limited Methods for improvement of visual function and compositions used therein
JP2016185939A (ja) * 2015-03-27 2016-10-27 ロート製薬株式会社 経口組成物
CN106174466A (zh) * 2015-05-26 2016-12-07 帝斯曼知识产权资产管理有限公司 一种口服营养组合物
CN106420816A (zh) * 2016-09-28 2017-02-22 北京瑞济善健康科技有限公司 缓解视疲劳和改善视觉功能的复方叶黄素固体制剂及其制备方法
CN109394838B (zh) * 2018-12-19 2021-05-07 安徽大学 一种治疗老年性黄斑变性的药物组合物
CN110075175A (zh) * 2019-05-16 2019-08-02 湖北思维特能生物科技有限公司 一种预防视网膜黄斑变性疾病的组合物
US20210322469A1 (en) * 2020-04-20 2021-10-21 Regents Of The University Of Minnesota Zinc and copper for the prophylaxis and treatment of covid-19
ES2969373B2 (es) * 2022-10-14 2025-02-06 Igen Biolab Group Ag Composicion obtenida de lisados de microorganismos probioticos para uso en el tratamiento y/o prevencion de las enfermedades degenerativas del ojo

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075116A (en) * 1989-04-20 1991-12-24 Lahaye Laboratories, Inc. Composition and method for treatment of macular degeneration
US5156852A (en) * 1989-04-20 1992-10-20 La Haye Laboratories, Inc. Composition and method for combating macular degeneration
GB9219524D0 (en) 1992-09-15 1992-10-28 Smithkline Beecham Plc Novel composition
US5739156A (en) 1994-09-21 1998-04-14 The Procter & Gamble Company Methods of using 2,4-dienoic acid esters of tocopherols to reduce free radical damage in mammalian cells
ATE355832T1 (de) 1995-06-07 2007-03-15 Howard Foundation Pharmazeutisch aktive karotenoide
ATE289808T1 (de) 1995-08-14 2005-03-15 Optigenex Inc Caroteinoid-nicotinamid-zink zusammensetzungen und verfahren zur behandlung unter verwendung derselben
US5948443A (en) 1996-02-23 1999-09-07 Medical Doctor's Research Institute, Inc. Acetylsalicylic acid and micronutrient supplementation for nutritional losses and coronary heart disease
US5976568A (en) 1997-02-21 1999-11-02 Medical Doctors' Research Institute, Inc. Modular system of dietary supplement compositions for optimizing health benefits and methods
US5770217A (en) 1997-07-02 1998-06-23 Atlatl, Inc. Dietary supplement for hematological, immune and appetite enhancement
EP0930072A1 (en) 1998-01-13 1999-07-21 Kartar Dr. Lalvani Vitamin and mineral containing compositions for the treatment of dry eye
US6103756A (en) * 1999-08-11 2000-08-15 Vitacost Inc. Ocular orally ingested composition for prevention and treatment of individuals
US6582721B1 (en) 1999-09-17 2003-06-24 Alcon, Inc. Stable carotene-xanthophyll beadlet compositions and methods of use
US6537581B2 (en) 2000-06-01 2003-03-25 Theralife, Inc. Compositions and methods for treating eye discomfort
DE20012510U1 (de) 2000-07-17 2000-11-30 Klingmüller, Martin, Dr., 26203 Wardenburg Multivitamin- und Mineralstoffpräparat
US6660297B2 (en) * 2001-03-23 2003-12-09 Bausch & Lomb Incorporated Nutritional supplement to treat macular degeneration

Similar Documents

Publication Publication Date Title
JP2004520436A5 (enExample)
Thomas et al. Nutrition and oral mucosal diseases
JP3672554B2 (ja) 黄斑変性を処置するための栄養補助剤
WO2005110375A8 (en) Nutritional supplement for treatment of ocular diseases
US20140256760A1 (en) Reduction or prevention of alcohol reaction with dietary supplements
JP4619003B2 (ja) 脱毛に対処するための医薬または栄養用の組成物
RU2009115791A (ru) Смесь солей железа и меди, маскирующая металлический вкус
Vyas et al. Antioxidants in oral diseases and future prospects and their application in dentistry
JP2005525329A5 (enExample)
CN106491452A (zh) 一种口腔护理剂及其制备方法
RU2665635C2 (ru) Мультивитаминная/минеральная композиция для борьбы с эффектами экологического стресса; повышения иммунитета и повышения активности, направленная на недостаточности витаминов и минералов без негативных побочных эффектов мегадозовой пищевой добавки
Boyd et al. Importance of nutrition for optimum health of the periodontium
CN111838679A (zh) 一种新型高效营养膳食补充剂
JP2004535453A (ja) 特に糖尿病患者の口腔衛生のための、フッ素イオンベクターおよび抗酸化剤を含む口腔衛生用組成物、ならびにその使用
TW202114644A (zh) 口服產品
Gupta et al. Effect of trans retinoic acid on patients with oral submucous fibrosis-randomized single-blind monocentric study
JP2002238496A (ja) 医療保健食品
de Castro et al. Physiologic alterations of oral mucosa due to aging: A review
KR20190012943A (ko) 구강작열감 증후군과 구내염 치료 및 예방용 조성물
ES2343119T3 (es) Composicion para la activacion del sistema inmune.
Sharma et al. A Short Review on Correlation Between Nutrition and Oral Health
Singh et al. Role of Nutraceuticals in Maintaining Oral and Periodontal Health
Winning et al. Relationship between periodontal disease and nutrition
JP2002201135A (ja) ラクツロースを含有する上腹部用組成物
Agbelusi Effects of nutrition on oral health